Jianying Dong

Title: Innovations and Contributions of Inventor Jianying Dong

Introduction

Jianying Dong is a notable inventor based in San Diego, CA, who has made significant contributions to the field of biotechnology. He holds a total of 3 patents that focus on monoclonal antibodies and their therapeutic applications. His work has implications for cancer treatment and other medical advancements.

Latest Patents

One of Jianying Dong's latest patents involves CD47 antibodies, which specifically bind to CD47 without causing significant platelet aggregation or hemagglutination. This patent outlines methods for generating these antibodies and their potential therapeutic uses. Another significant patent relates to antibodies directed to ERBB2, which includes human antibodies that inhibit ErbB2. This invention also covers various forms of antibodies, including chimeric and bispecific antibodies, and discusses methods for their use in diagnosis and treatment.

Career Highlights

Throughout his career, Jianying Dong has worked with prominent companies in the pharmaceutical industry, including Medimmune Limited and Janssen Pharmaceutica. His experience in these organizations has allowed him to develop innovative solutions in the field of antibody research.

Collaborations

Jianying Dong has collaborated with several professionals in his field, including Susan Ann Cartlidge and Mark Hickinson. These collaborations have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Jianying Dong's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments and therapies.